Citations

Gregson, J., P. Kaleebu, V. C Marconi, C. van Vuuren, N. Ndembi, R. L Hamers, P. Kanki, C. J Hoffmann, S. Lockman, D. Pillay, T. de Oliveira, N. Clumeck, G. Hunt, B. Kerschberger, R. W Shafer, C. Yang, E. Raizes, R. Kantor, and R. K Gupta. "Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study." Lancet Infect Dis 17, no. 3 (2017): 296-304.

Gupta, R. K, J. Gregson, N. Parkin, H. Haile-Selassie, A. Tanuri, L. Andrade Forero, P. Kaleebu, C. Watera, A. Aghokeng, N. Mutenda, J. Dzangare, S. Hone, Z. Z Hang, J. Garcia, Z. Garcia, P. Marchorro, E. Beteta, A. Giron, R. Hamers, R. Inzaule, L. M Frenkel, M. H Chung, T. de Oliveira, D. Pillay, K. Naidoo, A. Kharsany, R. Kugathasan, T. Cutino, G. Hunt, S. Avila Rios, M. Doherty, M. R Jordan, and S. Bertagnolio. "HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis." Lancet Infect Dis 18, no. 3 (2018): 346-355.

Collier, D., C. Iwuji, A. Derache, T. de Oliveira, N. Okesola, A. Calmy, F. Dabis, D. Pillay, R. K Gupta, French National Agency for, Aids, and Viral Hepatitis Research 12249 Treatment as Prevention Study, Group. "Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis." Clin Infect Dis 64, no. 8 (2017).

Goodall, R. L, D. T Dunn, P. Nkurunziza, L. Mugarura, T. Pattery, P. Munderi, C. Kityo, C. Gilks, P. Kaleebu, D. Pillay, R. K Gupta, and Dart Virology Group. "Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa." J Antimicrob Chemother 72, no. 5 (2017): 1450-1455.

Mlcochova, P., K. A Sutherland, S. A Watters, C. Bertoli, R. A de Bruin, J. Rehwinkel, S. J Neilands, G. M Lenzi, B. Kim, A. Khwaja, M. C Gage, C. Georgiou, A. Chittka, S. Yona, M. Noursadeghi, G. J Towers, and R. K Gupta. "A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages." EMBO J 36, no. 3 (2017): 604-616.

McCluskey, S. M, T. Pepperrell, A. Hill, W. D. F Venter, R. K Gupta, and M. J Siedner. "Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era." AIDS 35, no. Supplement 2 (2021): S127-S135.